Example of Graefe's Archive for Clinical and Experimental Ophthalmology format
Recent searches

Example of Graefe's Archive for Clinical and Experimental Ophthalmology format Example of Graefe's Archive for Clinical and Experimental Ophthalmology format Example of Graefe's Archive for Clinical and Experimental Ophthalmology format Example of Graefe's Archive for Clinical and Experimental Ophthalmology format Example of Graefe's Archive for Clinical and Experimental Ophthalmology format Example of Graefe's Archive for Clinical and Experimental Ophthalmology format Example of Graefe's Archive for Clinical and Experimental Ophthalmology format Example of Graefe's Archive for Clinical and Experimental Ophthalmology format Example of Graefe's Archive for Clinical and Experimental Ophthalmology format Example of Graefe's Archive for Clinical and Experimental Ophthalmology format Example of Graefe's Archive for Clinical and Experimental Ophthalmology format Example of Graefe's Archive for Clinical and Experimental Ophthalmology format Example of Graefe's Archive for Clinical and Experimental Ophthalmology format Example of Graefe's Archive for Clinical and Experimental Ophthalmology format Example of Graefe's Archive for Clinical and Experimental Ophthalmology format Example of Graefe's Archive for Clinical and Experimental Ophthalmology format Example of Graefe's Archive for Clinical and Experimental Ophthalmology format Example of Graefe's Archive for Clinical and Experimental Ophthalmology format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Graefe's Archive for Clinical and Experimental Ophthalmology format Example of Graefe's Archive for Clinical and Experimental Ophthalmology format Example of Graefe's Archive for Clinical and Experimental Ophthalmology format Example of Graefe's Archive for Clinical and Experimental Ophthalmology format Example of Graefe's Archive for Clinical and Experimental Ophthalmology format Example of Graefe's Archive for Clinical and Experimental Ophthalmology format Example of Graefe's Archive for Clinical and Experimental Ophthalmology format Example of Graefe's Archive for Clinical and Experimental Ophthalmology format Example of Graefe's Archive for Clinical and Experimental Ophthalmology format Example of Graefe's Archive for Clinical and Experimental Ophthalmology format Example of Graefe's Archive for Clinical and Experimental Ophthalmology format Example of Graefe's Archive for Clinical and Experimental Ophthalmology format Example of Graefe's Archive for Clinical and Experimental Ophthalmology format Example of Graefe's Archive for Clinical and Experimental Ophthalmology format Example of Graefe's Archive for Clinical and Experimental Ophthalmology format Example of Graefe's Archive for Clinical and Experimental Ophthalmology format Example of Graefe's Archive for Clinical and Experimental Ophthalmology format Example of Graefe's Archive for Clinical and Experimental Ophthalmology format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access

Graefe's Archive for Clinical and Experimental Ophthalmology — Template for authors

Publisher: Springer
Categories Rank Trend in last 3 yrs
Ophthalmology #18 of 116 -
Sensory Systems #15 of 40 down down by 1 rank
Cellular and Molecular Neuroscience #64 of 88 down down by 2 ranks
journal-quality-icon Journal quality:
High
calendar-icon Last 4 years overview: 1119 Published Papers | 4955 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 16/07/2020
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access
recommended Recommended

BMJ Publishing Group

Quality:  
High
CiteRatio: 7.3
SJR: 2.016
SNIP: 2.055
open access Open Access

Elsevier

Quality:  
High
CiteRatio: 4.9
SJR: 1.217
SNIP: 1.063
open access Open Access

Frontiers Media

Quality:  
High
CiteRatio: 5.7
SJR: 2.036
SNIP: 1.066
open access Open Access
recommended Recommended

Elsevier

Quality:  
High
CiteRatio: 28.6
SJR: 7.198
SNIP: 6.31

Journal Performance & Insights

Impact Factor

CiteRatio

Determines the importance of a journal by taking a measure of frequency with which the average article in a journal has been cited in a particular year.

A measure of average citations received per peer-reviewed paper published in the journal.

2.396

6% from 2018

Impact factor for Graefe's Archive for Clinical and Experimental Ophthalmology from 2016 - 2019
Year Value
2019 2.396
2018 2.25
2017 2.249
2016 2.349
graph view Graph view
table view Table view

4.4

5% from 2019

CiteRatio for Graefe's Archive for Clinical and Experimental Ophthalmology from 2016 - 2020
Year Value
2020 4.4
2019 4.2
2018 3.9
2017 4.2
2016 4.3
graph view Graph view
table view Table view

insights Insights

  • Impact factor of this journal has increased by 6% in last year.
  • This journal’s impact factor is in the top 10 percentile category.

insights Insights

  • CiteRatio of this journal has increased by 5% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

1.196

5% from 2019

SJR for Graefe's Archive for Clinical and Experimental Ophthalmology from 2016 - 2020
Year Value
2020 1.196
2019 1.265
2018 1.177
2017 1.314
2016 1.31
graph view Graph view
table view Table view

1.258

8% from 2019

SNIP for Graefe's Archive for Clinical and Experimental Ophthalmology from 2016 - 2020
Year Value
2020 1.258
2019 1.165
2018 1.031
2017 1.054
2016 1.192
graph view Graph view
table view Table view

insights Insights

  • SJR of this journal has decreased by 5% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has increased by 8% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

Graefe's Archive for Clinical and Experimental Ophthalmology

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

Springer

Graefe's Archive for Clinical and Experimental Ophthalmology

Graefe's Archive for Clinical and Experimental Ophthalmology is a distinguished international journal that presents original clinical reports and clinically relevant experimental studies. Founded in 1854 by Albrecht von Graefe to serve as a source of useful clinical informatio...... Read More

Ophthalmology

Sensory Systems

Cellular and Molecular Neuroscience

Medicine

i
Last updated on
16 Jul 2020
i
ISSN
0721-832X
i
Impact Factor
High - 1.278
i
Open Access
Yes
i
Sherpa RoMEO Archiving Policy
Green faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Bibliography Name
SPBASIC
i
Citation Type
Author Year
(Blonder et al, 1982)
i
Bibliography Example
Beenakker CWJ (2006) Specular andreev reflection in graphene. Phys Rev Lett 97(6):067,007, URL 10.1103/PhysRevLett.97.067007

Top papers written in this journal

Journal Article DOI: 10.1007/S004170000188
Comparison of immersion ultrasound biometry and partial coherence interferometry for intraocular lens calculation according to Haigis

Abstract:

Background: The precision of intraocular lens (IOL) calculation is essentially determined by the accuracy of the measurement of axial length. In addition to classical ultrasound biometry, partial coherence interferometry serves as a new optical method for axial length determination. A functional prototype from Carl Zeiss Jena... Background: The precision of intraocular lens (IOL) calculation is essentially determined by the accuracy of the measurement of axial length. In addition to classical ultrasound biometry, partial coherence interferometry serves as a new optical method for axial length determination. A functional prototype from Carl Zeiss Jena implementing this principle was compared with immersion ultrasound biometry in our laboratory. Patients and methods: In 108 patients attending the biometry laboratory for planning of cataract surgery, axial lengths were additionally measured optically. Whereas surgical decisions were based on ultrasound data, we used postoperative refraction measurements to calculate retrospectively what results would have been obtained if optical axial length data had been used for IOL calculation. For the translation of optical to geometrical lengths, five different conversion formulas were used, among them the relation which is built into the Zeiss IOLMaster. IOL calculation was carried out according to Haigis with and without optimization of constants. Results: On the basis of ultrasound immersion data from our Grieshaber Biometric System (GBS), postoperative refraction after implantation of a Rayner IOL type 755U was predicted correctly within ±1 D in 85.7% and within ±2 D in 99% of all cases. An analogous result was achieved with optical axial length data after suitable transformation of optical path lengths into geometrical distances. Conclusions: Partial coherence interferometry is a non- contact, user- and patient-friendly method for axial length determination and IOL planning with an accuracy comparable to that of high-precision immersion ultrasound. read more read less

Topics:

Intraocular lens power calculation (59%)59% related to the paper, Intraocular lens (51%)51% related to the paper, Optical path (50%)50% related to the paper
579 Citations
Journal Article DOI: 10.1007/BF00175988
Improvements on Littmann's method of determining the size of retinal features by fundus photography.
Bennett Ag1, Alicja R. Rudnicka2, David F Edgar2

Abstract:

Littmann's formula relating the size of a retinal feature to its measured image size on a telecentric fundus camera film is widely used. It requires only the corneal radius, ametropia, and Littmann's factor q obtained from nomograms or tables. These procedures are here computerized for practitioners' convenience. Basic optica... Littmann's formula relating the size of a retinal feature to its measured image size on a telecentric fundus camera film is widely used. It requires only the corneal radius, ametropia, and Littmann's factor q obtained from nomograms or tables. These procedures are here computerized for practitioners' convenience. Basic optical principles are discussed, showing q to be a constant fraction of the theoretical ocular dimension k′, the distance from the eye's second principal point to the retina. If the eye's axial length is known, three new methods of determining q become available: (a) simply reducing the axial length by a constant 1 · 82 mm; (b) constructing a personalized schematic eye, given additional data; (c) ray tracing through this eye to extend calculations to peripheral retinal areas. Results of all these evaluations for 12 subjects of known ocular dimensions are presented for comparison. Method (a), the simplest, is arguably the most reliable. It shows good agreement with Littmann's supplementary procedure when the eye's axial length is known. read more read less
516 Citations
Journal Article DOI: 10.1007/S00417-007-0660-Z
Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES).

Abstract:

Vascular endothelial growth factor (VEGF) plays an important role in many diseases of the posterior pole that are characterized by macular edema and/or intraocular neovascularization. Recently anti-VEGF agents such as ranibizumab and pegaptanib sodium have been shown to be beneficial in the treatment of choroidal neovasculari... Vascular endothelial growth factor (VEGF) plays an important role in many diseases of the posterior pole that are characterized by macular edema and/or intraocular neovascularization. Recently anti-VEGF agents such as ranibizumab and pegaptanib sodium have been shown to be beneficial in the treatment of choroidal neovascularization (CNV) secondary to age-related macular degeneration (ARMD). However in most parts of the world, both pegaptanib sodium and ranibizumab are not readily available. Bevacizumab, a humanized recombinant monoclonal IgG antibody that binds and inhibits all VEGF isoforms, has been proposed as an alternative treatment option. A total of 1,265 consecutive patients were injected with bevacizumab for diseases such as proliferative diabetic retinopathy, diabetic macular edema, retinal vein occlusions, and CNV of several etiologies including ARMD at eight Latin American institutions from 1 September 2005 to 31 January 2006. Of these 1,265, 92 were excluded because they were injected once and lost to follow-up. The remaining 1,173 patients constitute the subjects of this retrospective, multicenter, open label, uncontrolled interventional case series that reports the cumulative systemic and ocular adverse events following intravitreal bevacizumab during 12 months of follow-up. Patients were examined at baseline and then monthly. If the patients were unable to attend the 12-month visit, a telephone interview was conducted to assess for possible systemic complications. A total of 4,303 intravitreal injections of bevacizumab on 1,310 eyes was reported. All 1,173 patients were accounted for at the 12-month visit. Systemic adverse events were reported in 18 (1.5%) patients. These included seven (0.59%) cases of an acute elevation of systemic blood pressure, six (0.5%) cerebrovascular accidents, five (0.4%) myocardial infarctions, two (0.17%) iliac artery aneurysms, two (0.17%) toe amputations and five (0.4%) deaths. Ocular complications included seven (0.16%) bacterial endophthalmitis, seven (0.16%) tractional retinal detachments, four (0.09%) uveitis, and a case (0.02%) each of rhegmatogenous retinal detachment and vitreous hemorrhage. Despite the limited follow-up, repeated intravitreal injections of either 1.25 mg or 2.5 mg of bevacizumab appears to be safe and well tolerated during the 1st year. read more read less

Topics:

Ranibizumab (68%)68% related to the paper, Macular edema (56%)56% related to the paper, Choroidal neovascularization (56%)56% related to the paper, Bevacizumab (55%)55% related to the paper, Diabetic retinopathy (54%)54% related to the paper
450 Citations
Journal Article DOI: 10.1007/S00417-008-0926-0
Resolving the clinical acuity categories "hand motion" and "counting fingers" using the Freiburg Visual Acuity Test (FrACT).
Clemens Lange1, Nicolas Feltgen1, Bernd Junker1, K. Schulze-Bonsel1, Michael Bach1

Abstract:

The Freiburg Visual Acuity Test (FrACT) has been suggested as a promising test for quantifying the visual acuity (VA) of patients with very low vision, a condition often classified using the semi-quantitative clinical scale “counting fingers” (CF), “hand motion” (HM), “light perception” (LP) and “no light perception”. The pre... The Freiburg Visual Acuity Test (FrACT) has been suggested as a promising test for quantifying the visual acuity (VA) of patients with very low vision, a condition often classified using the semi-quantitative clinical scale “counting fingers” (CF), “hand motion” (HM), “light perception” (LP) and “no light perception”. The present study was designed to assess FrACT performance in a sizable number of CF, HM, and LP patients in order to generate a setting for future clinical studies in the low vision range. We examined a total of 41 patients (LP, n = 11; CF, n = 15; HM, n = 15) with various eye diseases (e.g., diabetic retinopathy, ARMD), covering the clinical VA scale from LP to CF. The FrACT optotypes were presented at a distance of 50 cm on a 17-inch LCD monitor with four random orientations. After training, two FrACT measurements (test and retest) were taken, each comprising 30 trials. FrACT measures reproducibly the VA of CF and HM patients. In CF patients, FrACT resulted in a mean logMAR = 1.98 ± 0.24 (corresponding to a decimal VA of 0.010), for HM in a mean logMAR = 2.28 ± 0.15 (corresponding to a decimal VA of 0.0052). In all LP patients the FrACT values were close to what would be obtained by random guessing. The mean test–retest 95% confidence interval was 0.21 logMAR for CF patients and 0.31 logMAR for HM respectively. Test-retest variability declined from 24 to 30 trials, showing that at least 30 trials are necessary. FrACT can reproducibly quantify VA in the CF and HM range. We observed a floor effect for LP, and it was not quantifiable further. Quantitative VA measures are thus obtainable in the very low-vision range using FrACT. read more read less
430 Citations
Journal Article DOI: 10.1007/S00417-004-0980-1
Anomalous posterior vitreous detachment: a unifying concept in vitreo-retinal disease
Jerry Sebag1

Abstract:

Posterior vitreous detachment (PVD) is the consequence of changes in the macromolecular structure of gel vitreous that result in liquefaction, concurrent with alterations in the extracellular matrix at the vitreo-retinal interface that allow the posterior vitreous cortex to detach from the internal limiting lamina of the reti... Posterior vitreous detachment (PVD) is the consequence of changes in the macromolecular structure of gel vitreous that result in liquefaction, concurrent with alterations in the extracellular matrix at the vitreo-retinal interface that allow the posterior vitreous cortex to detach from the internal limiting lamina of the retina. Gel liquefaction that exceeds the degree of vitreo-retinal dehiscence results in anomalous PVD (APVD). APVD varies in its clinical manifestations depending upon where in the fundus vitreo-retinal adhesion is strongest. At the periphery, APVD results in retinal tears and detachments. In the macula, APVD causes vitreo-macular traction syndrome, results in vitreoschisis with macular pucker or macular holes, or contributes to some cases of diabetic macular edema. At the optic disc and retina, APVD causes vitreo-papillary traction and promotes retinal and optic disc neovascularization. Unifying the spectrum of vitreo-retinal diseases into the conceptual framework of APVD underscores that to more effectively treat, and ultimately prevent, these disorders it is necessary to replicate the two components of an innocuous PVD, i.e., gel liquefaction and vitreo-retinal dehiscence. Pharmacologic vitreolysis is designed to mitigate against APVD by chemically breaking down vitreous macromolecules and weakening vitreo-retinal adhesion to safely detach the posterior vitreous cortex. This would not only facilitate surgery, but if performed early in the natural history of disease, it should prevent progressive disease. read more read less

Topics:

Posterior vitreous detachment (70%)70% related to the paper, Vitreous Detachment (65%)65% related to the paper, Vitreous membrane (63%)63% related to the paper, Vitreomacular adhesion (61%)61% related to the paper, Retinal Tear (58%)58% related to the paper
422 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Graefe's Archive for Clinical and Experimental Ophthalmology.

It automatically formats your research paper to Springer formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Graefe's Archive for Clinical and Experimental Ophthalmology format uses SPBASIC citation style.

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write Graefe's Archive for Clinical and Experimental Ophthalmology in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the Graefe's Archive for Clinical and Experimental Ophthalmology guidelines and auto format it.

2. Do you follow the Graefe's Archive for Clinical and Experimental Ophthalmology guidelines?

Yes, the template is compliant with the Graefe's Archive for Clinical and Experimental Ophthalmology guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in Graefe's Archive for Clinical and Experimental Ophthalmology?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the Graefe's Archive for Clinical and Experimental Ophthalmology citation style.

4. Can I use the Graefe's Archive for Clinical and Experimental Ophthalmology templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for Graefe's Archive for Clinical and Experimental Ophthalmology.

5. Can I use a manuscript in Graefe's Archive for Clinical and Experimental Ophthalmology that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper Graefe's Archive for Clinical and Experimental Ophthalmology that you can download at the end.

6. How long does it usually take you to format my papers in Graefe's Archive for Clinical and Experimental Ophthalmology?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in Graefe's Archive for Clinical and Experimental Ophthalmology.

7. Where can I find the template for the Graefe's Archive for Clinical and Experimental Ophthalmology?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Graefe's Archive for Clinical and Experimental Ophthalmology's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the Graefe's Archive for Clinical and Experimental Ophthalmology's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. Graefe's Archive for Clinical and Experimental Ophthalmology an online tool or is there a desktop version?

SciSpace's Graefe's Archive for Clinical and Experimental Ophthalmology is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like Graefe's Archive for Clinical and Experimental Ophthalmology?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like Graefe's Archive for Clinical and Experimental Ophthalmology?”

11. What is the output that I would get after using Graefe's Archive for Clinical and Experimental Ophthalmology?

After writing your paper autoformatting in Graefe's Archive for Clinical and Experimental Ophthalmology, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is Graefe's Archive for Clinical and Experimental Ophthalmology's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for Graefe's Archive for Clinical and Experimental Ophthalmology?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for Graefe's Archive for Clinical and Experimental Ophthalmology. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In Graefe's Archive for Clinical and Experimental Ophthalmology?

The 5 most common citation types in order of usage for Graefe's Archive for Clinical and Experimental Ophthalmology are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the Graefe's Archive for Clinical and Experimental Ophthalmology?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Graefe's Archive for Clinical and Experimental Ophthalmology's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download Graefe's Archive for Clinical and Experimental Ophthalmology in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in Graefe's Archive for Clinical and Experimental Ophthalmology Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Graefe's Archive for Clinical and Experimental Ophthalmology formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template